EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA1c levels in db/db mice and prolongs the survival of stroke-prone rats

Poor Control of Risk Factors for Vascular Disease Among Adults With Previously Diagnosed Diabetes

Sharon Saydah · JAMA · 2004 · 1.4K citations

Medicine, Chronic Disease Control, Internal Medicine +16

Glucose Transporters in Human Renal Proximal Tubular Cells Isolated From the Urine of Patients With Non–Insulin-Dependent Diabetes

Hassan Rahmoune, Paul Thompson, Joanna M. Ward et al. · Diabetes · 2005 · 768 citations · Full text

Medicine, Cell Biology, Endocrinology +17

Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes

James F. List, Vincent Woo, Enrique Morales et al. · Diabetes Care · 2008 · 696 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Discovery of Dapagliflozin: A Potent, Selective Renal Sodium-Dependent Glucose Cotransporter 2 (SGLT2) Inhibitor for the Treatment of Type 2 Diabetes

Wei Meng, Bruce A. Ellsworth, Alexandra A. Nirschl et al. · Journal of Medicinal Chemistry · 2008 · 628 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose.

Y. Kanai, W S Lee, Dennis Brown et al. · Journal of Clinical Investigation · 1994 · 624 citations · Full text

Life Sciences, Molecular Biology, Physiology +15